I hear you, Al. Bios are dangerous stocks. The science is exciting, but so often the business end appears to be as cluttered as a messy office. Good science and good drug development do not always translate to good company to invest in. This one has its head in the sand when it comes to caring for its stockholders. Eventually it will be sold for $2 per share if that.
Too big a mess to recover.
JMHO
opti
Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.